Xin Yang, PHARMD | |
2037 Verdugo Blvd, Montrose, CA 91020-1626 | |
(818) 248-8018 | |
Not Available |
Full Name | Xin Yang |
---|---|
Gender | Male |
Speciality | Pharmacist |
Location | 2037 Verdugo Blvd, Montrose, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1578928255 | NPI | - | NPPES |
1922049832 | Medicaid | CA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 69668 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Xin Yang, PHARMD 2037 Verdugo Blvd, Montrose, CA 91020-1626 Ph: (818) 248-8018 | Xin Yang, PHARMD 2037 Verdugo Blvd, Montrose, CA 91020-1626 Ph: (818) 248-8018 |
News Archive
AFFiRiS, a clinical-stage biotechnology company developing novel disease-modifying specific active immunotherapies, today announced that detailed preclinical results with its monoclonal antibody mAB C6-17 to treat Huntington's Disease were published in the peer-reviewed journal Neurobiology of Disease.
In 1999 and 2003, an H9N2 influenza strain caused illness in three people in Hong Kong. Scientists are concerned about H9N2 and other emerging types of avian influenza viruses because as they spread—most commonly through poultry—they continually mutate, increasing chances that they may infect humans, evade the body's immune response and become more lethal.
Have you ever felt like you needed a drink? If an occasional cocktail changes into a need, it could mean an alcohol problem. National Alcohol Screening Day is April 8. In cities and towns throughout the United States, screening programs will be offered to help people determine whether they exhibit drinking behaviors that could be signs of alcohol addiction.
Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced that it has entered into an exclusive US $75 million license agreement with Kissei Pharmaceutical Co., Ltd. for the development and commercialization of its PSA-activated pro-drug, PRX302, in Japan for BPH, prostate cancer and other diseases of the prostate. Protox retains exclusive rights to PRX302 in all other territories.
A team of Duke University researchers has developed a lab-grown living lung model that mimics the tiny air sacs of the lungs where coronavirus infection and serious lung damage take place.
› Verified 4 days ago
Mania Gharibian, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2037 Verdugo Blvd, Montrose, CA 91020 Phone: 818-248-8018 | |
Zohrab Khacheryan, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2037 Verdugo Blvd, Montrose, CA 91020 Phone: 323-333-4074 | |
Nicole Ouzounian, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2037 Verdugo Blvd, Montrose, CA 91020 Phone: 818-248-8018 | |
Thuan Minh Hoang, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2037 Verdugo Blvd, Montrose, CA 91020 Phone: 818-248-8018 | |
Garo Boyajian, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2037 Verdugo Blvd, Montrose, CA 91020 Phone: 818-248-8018 | |
Erebooni Annie Aslanian, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2037 Verdugo Blvd, Montrose, CA 91020 Phone: 818-248-8018 | |
Dr. Renia Shahjahanian, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2727 Montrose Ave Apt 5, Montrose, CA 91020 Phone: 818-468-9311 |